Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Return on Capital Employed [ROCE] of 29.60% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 11.09 percentage points from 40.69% a year earlier and down 2.59 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals posted Return on Capital Employed [ROCE] of 49.14%, up 24.07 percentage points from FY2025.

  • Return on Capital Employed [ROCE] has increased for three consecutive fiscal years, with a five-year change of +38.49 percentage points (FY2021 to FY2026).
  • By fiscal year, Return on Capital Employed [ROCE] came in at 25.07% in FY2025 (+3.15 pp), 21.92% in FY2024 (+9.74 pp), 12.18% in FY2023 (-8.97 pp) and 21.15% in FY2022 (+10.50 pp).
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q4 2025.
  • Year over year, Return on Capital Employed [ROCE] gained in six of the last eight quarters, with an average year-over-year change of +10.53 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was fiscal Q3 2026 (a gain of 29.82 percentage points); the low point was fiscal Q2 2027 (a drop of 11.09 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at 32.19% (Q1 2027), 42.72% (Q4 2026) and 46.10% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.52%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 21.60%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.65%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.15%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 11.32%
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 29.60%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 29.60%
Jun 30, 2026 32.19%
Mar 31, 2026 42.72%
Dec 31, 2025 46.10%
Sep 30, 2025 40.69%
Jun 30, 2025 40.21%
Mar 31, 2025 23.98%
Dec 31, 2024 16.28%
Sep 30, 2024 19.44%
Jun 30, 2024 18.19%
Mar 31, 2024 16.32%
Dec 31, 2023 12.46%
Sep 30, 2023 12.90%
Jun 30, 2023 13.46%
Mar 31, 2023 9.43%
Dec 31, 2022 10.95%
Sep 30, 2022 11.29%
Jun 30, 2022 14.84%
Mar 31, 2022 18.88%
Dec 31, 2021 12.40%
API Access

Elite Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY